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Marine  environment  is  one  of  the  most  important  sources  regarding  natural  products  research.  Besides,
marine  microorganisms  have  been  denominated  as  a talented  natural  source  for  discovery  of  new leads.
Although  the  association  of  macroalgae  and  fungi  has  been  described  regarding  ecological  issues,  there
is a lack  of  studies  about  marine  seaweed  endophytic  fungi.  In  this  context,  the  goal  of  this  study  was
to  evaluate  cytotoxic,  antifungal  and  antibacterial  activities  of endophytic  fungi  isolated  from  the  Brazil-
ian  marine  seaweed  Bostrychia  tenella  (J.V.  Lamouroux)  J. Agardh  (Ceramiales,  Rhodophyta).  Forty-ﬁve
endophytic  microorganism  strains  were  isolated  from  B.  tenella.  Crude  extracts  and  organic  fractions  of
ten  selected  strains  were  obtained  after  growth  in  rice  medium.  Samples  were  evaluated  for  cytotoxicity,
antifungal  and  antibacterial  assays.  Penicillium  strains  showed  positive  results  in a diversity  of assays,  and
other  ﬁve  strains  were  active  in  at least  one  test.  In addition,  cytochalasin  D was  isolated  from  Xylaria
sp.  This  alga  is  composed  of  a  microbiological  potential,  since  its  endophytic  strains  exhibited  remark-
able  biological  properties.  Moreover,  cytochalasin  D  isolation  has  conﬁrmed  chemical  potential  of  marine
endophytic  strains.  This  is the  ﬁrst  study  in  which  cultured  fungi  isolates  from  the  Brazilian  macroalga
B.  tenella  were  evaluated  concerning  biological  properties.  Results  corroborated  that  this  species  could  be
a  pharmaceutical  source  from  marine  environment.  Furthermore,  Acremonium  implicatum  is being  ﬁrstly
described  as  marine  endophyte  and  Xylaria  sp.,  Trichoderma  atroviride  and  Nigrospora  oryzae  as  marine
seaweed  endophytes.  Thus,  this  work  reports  the ﬁrst study  relating  detailed  isolation,  cultivation  and
biological  evaluation  (cytotoxic,  antifungal  and  antibacterial)  of endophytes  Penicillium  decaturense  and
P. waksmanii  from  the  Brazilian  marine  red alga  B.  tenella.  We  are  also  reporting  the  isolation  of cytocha-
lasin  D,  a  known  antitumor  and  antibiotic  compound,  from  Xylaria  sp.  strain.  Despite  widespread
prevalence  in terrestrial  and  marine  habitats,  this  present  work  describes  the  ﬁrst  occurrence  of  cytocha-
lasin  D as  a  metabolite  from  marine  seaweed  endophyte.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroductionMarine environment is currently pointed as one of the most
mportant sources regarding natural products research ﬁeld, since
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http://dx.doi.org/10.1016/j.bjp.2015.08.003
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraorganisms from oceans have been exhibited remarkable biologi-
cal, biochemical and biosynthetic potential (Gerwick and Moore,
2012; Mayer et al., 2010, 2011; Molinski et al., 2009; Newman and
Cragg, 2014). Biodiversity is very expressive concerning high taxo-
nomic levels: from 76 phyla described for Eukariota,  about sixty can
be found in marine areas, meanwhile forty for terrestrial or fresh-
water environments (Blunt et al., 2013). Marine natural products
research have often been mentioned as fundamental for discovery
 Ltda. All rights reserved.
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f new chemical structures, mainly for featuring unusual mecha-
isms of action (Molinski et al., 2009). In a recent data, up to 2009,
840 marine species have been investigated resulting on the isola-
ion of 20,057 metabolites, which were published in 7795 articles.
espite exciting numbers, considering the total of 250,000 recog-
ized marine species, it is estimated that only 1% of them have
lready been studied (Blunt et al., 2013), which means there are an
mazing roll of unexplored living beings comprising chemical and
iological treasures.
Similarly, microbial natural products represent an extensive
rea for new therapeutic compounds search (Berdy, 2012; Cragg
nd Newman, 2013; Demain, 2014; Vederas and Li, 2009; Walsh
nd Fischbach, 2010). Relevant reviews emphasized microbial
etabolites as targets for discovery and development of new drugs,
ostly anticancer and antibiotics (Berdy, 2012; Butler et al., 2013;
emain, 2014), antifungals, antiparasitics, among others (Amedei
nd D’Elios, 2012). Microorganisms are very versatile and found
verywhere, even in inhospitable habitats, in all ecosystems around
he globe. It is preconized that less than 1% of all bacteria species
nd less than 5% of all fungi species are described, suggesting at least
0 million microbial species are unknown, remaining hidden in
ature (Berdy, 2012). Besides, based on genetic researches, 90% of
iosynthetic skill of microorganisms keeps unattainable, what rati-
es the signiﬁcance of microbial natural products research for drug
iscovery and, even for complete biodiversity knowledge and eco-
ogical relationships understanding (Walsh and Fischbach, 2010).
Additionally, assembling these concepts and overlapping
emarkable uncharted ﬁelds, marine microorganisms have been
enominated as a talented natural source for discovery of new
eads, for showing notable biosynthetic ability as producers of func-
ional metabolites (Blunt et al., 2013; Cragg and Newman, 2013;
enical and Jensen, 2006; Gerwick and Fenner, 2013; Gerwick and
oore, 2012). Predicted numbers suggest approximately 3.7 × 1030
icroorganisms ﬁghting for survival in oceans and seas, most own-
ng extraordinary undiscovered biochemistry (Fenical and Jensen,
006; Li and Vederas, 2009). In this context, there are few evidences
roving that invertebrate marine hosts and microorganisms estab-
ish an intense symbiotic relationship, since several prospections
ndicated that active substances produced by sponges, tunicate, soft
orals etc., are actually microbial products (Dorrestein et al., 2008;
erwick and Fenner, 2013; Gerwick and Moore, 2012; Glaser and
ayer, 2009).
Twenty approved marine drugs and/or in clinical or preclinical
rials were organized accordingly ﬁeld collected source and biosyn-
hesis pathways origin source (Gerwick and Moore, 2012). In this
ork, authors have strongly proponed that heterotrophic bacte-
ia and cyanobacteria are the real ocean biologic treasures, being
enetically responsible for 80% of these previously mentioned
arine leads. Moreover, with the advance of genetic techniques
hat will allow isolation and expression of biosynthetic clusters,
icroorganisms and respective marine invertebrate hosts will rep-
esent a new frontier for natural products drug discovery (Cragg and
ewman, 2013).
Concerning ecological issues, it is reasonable to exploit the
peciﬁc role of endophytic microorganisms in marine life style.
ome authors have been described endophytes as any microbe
hat spends part of their life cycle in plant host health tissues, in
 balance relationship that can alternate between latent patho-
enesis and mutualistic symbiosis (Kusari et al., 2013). However,
he widely spread deﬁnition explains that an endophytic microor-
anism is a fungus or bacteria that colonizes plants inner tissues
ffering no apparent impact to hosts (Gutierrez et al., 2012; Zhao
t al., 2011). Despite slight differences, there is a common agree-
ent about an evident genic intercommunication between hosts
nd endophytes, strongly proved by shared metabolic abilities
Gutierrez et al., 2012; Kusari et al., 2013; Zhao et al., 2011).armacognosia 25 (2015) 641–650
They present chemical diversity, since are producers of alkaloids,
terpenoids, ﬂavonoids, steroids, besides owners of biological rich-
ness (Guo et al., 2008). Recent works have reported the isolation
of antitumor compounds from endophytic fungi of plants, thus
arousing the interest of scientiﬁc community. Paclitaxel, camp-
totecin, podophyllotoxin, vinblastine and vincristine were detected
in endophytes obtained from original producer plant (Cragg and
Newman, 2013; Kusari et al., 2013; Zhao et al., 2011).
The association of macroalgae and fungi has been already
described regarding ecological issues; however, there is a lack
of studies about marine seaweed endophytic fungi, especially
from tropical/subtropical regions (Jones et al., 2008). Recently,
about eighty unknown and/or bioactive metabolites isolated from
endophytic fungi associated to marine macroalgae (Chlorophyta,
Phaeophyta e Rhodophyta) were reviewed (Leandrini de Oliveira
et al., 2012), indicating an impressive chemical and biological diver-
sity from these poorly explored source of natural compounds.
According to the issues reported above, we  found it could be
very interesting to work in a new research frontier, by exploring
endophytic microorganism from marine red alga Bostrychia tenella
(J.V. Lamouroux) J. Agardh (Rhodomelaceae, Ceramiales). Aiming
to develop this purpose, endophytic fungi were isolated and culti-
vated under laboratories conditions, and their crude extracts (CE)
were evaluated in cytotoxic, antifungal and antibacterial assays.
B. tenella belongs to Rhodomelaceae family, the most important
in Rhodophyta phyla, and pointed as halogenated metabolites
producers, many of which present unusual carbonic frame and
bioactivity (Suzuki and Vairappan, 2005). In a previous study of our
research group involving B. tenella,  we reported active volatile apo-
lar fractions against the parasites Trypanosoma cruzi and Leishmania
amazonensis, as well against Cladosporium cladosporioides and C.
sphaerospermum fungi (de Felicio et al., 2010).
It has been reported a screening for evaluating promissory
sources of novel and biologically active metabolites, comparing
endophytic from aquatic plants and algae associated fungi, includ-
ing B. tenella.  However, both unknown metabolites and strains
microorganism isolation were not attributed clearly for B. tenella.
Furthermore, the applied methodology was  not satisfactory for
classifying the strains as endophytic (Schulz et al., 2008). Thus,
this is the ﬁrst work relating detailed isolation, cultivation and
biological evaluation (cytotoxic, antifungal and antibacterial) of
endophytes from the Brazilian marine red alga B. tenella.
In order to validate chemical potential of marine seaweed
endophytes, in this work, we  are also reporting the isolation of
cytochalasin D (1), a known antitumor and antibiotic compound,
from Xylaria sp. strain. Despite widespread prevalence in terres-
trial and marine habitats, this present work describes the ﬁrst
occurrence of cytochalasin D as a metabolite from marine seaweed
endophyte.
Materials and methods
Isolation of endophytic microorganisms associated to B. tenella
Algae collection and superﬁcial sterilization
Bostrychia tenella (J.V. Lamouroux) J. Agardh specimens were
collected in rocky shores located at Praia Dura, Ubatuba city, São
Paulo state, Brazil (23◦20′07′′S, 45◦10′27′′W),  in September 2008.
Voucher specimens were deposited in the herbarium of Instituto
de Botânica (Herbarium SP), with the accession number SP 371456.
The general procedures adopted for isolation of the microorgan-
isms were proposed based in previously described methodologies
(Erbert et al., 2012; Proksch et al., 2010). The algal material was
cleaned in seawater, stored in ﬂasks with sterilized seawater sup-
plemented with chloramphenicol (200 mg  l−1), and maintained in
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ow temperature. Aseptically, the algal material was  fragmented
ith scalpel and separated in three parts, in which each part was
ubmitted to different superﬁcial sterilization methods (SSM): (i)
5 s in ethanol 70%; (ii) 5 s in ethanol 70% and 5 s in sodium
ypochlorite (NaOCl); (iii) 5 s in ethanol 70% and 10 s in NaOCl.
fter each SSM, thallus fragments were rinsed in three sequen-
ial sterilized seawater recipients and inoculated in Petri dishes
13–15 fragments/plate) containing semi-solid medium: potato-
extrose-agar (PDA) or algae-dextrose-agar (ADA), supplemented
ith chloramphenicol (200 mgL−1). For efﬁcacy control of algal
halli sterilization, drops of the last wash seawater were plated
n other medium Petri dishes (PDA and ADA) as well as sterilized
hallus were touched in medium plates control before inoculation.
rowth and control plates were incubated at 30 ◦C, and periodically
bserved.
ndophytic strains isolation and preservation
Microorganism colonies were growing around sterilized thalli
ragments in semi-solid medium plates. For strains isolation,
ycelial discs were taken from growing plates and inoculated in
DA plates. Once isolated, strains preservation were performed
sing sterile penicillin tubes containing PDA medium and mineral
il.
rude extracts and fractions obtained from B. tenella endophytes
From the total number puriﬁed endophytic strains, ten of them
BT01–BT10) were selected to growth in rice solid medium. The
election criteria were relied based on visual and morphological dif-
erences, in order to choose distinguished strains from each other,
aking into account coloration and macroscopic morphoanatomical
tructures.
Each selected strain was growth in PDA plates for 15–20 days,
t 30 ◦C. In sequence, ten discs of agar containing mycelium
ere added in two Erlenmeyers ﬂaks (500 ml) containing 90 g
f sterilized rice. Flasks were maintained at room temperature
at 25 ± 2 ◦C), for 28 days. For organic extraction, rice cultured
as submitted to maceration in methanol for 24 h twice. It was
ade a control culture containing only rice solid medium. The CE
ere concentrated under reduced pressure and, in sequence, they
ere dissolved in MeOH:H2O (9:1) and submitted to liquid–liquid
artition, yielding n-hexane (HF), ethyl acetate (EF) and hydroalco-
olic (MF) fractions. Forty-four samples (CE and organic fractions)
f ten strains and one culture control were reached and submitted
o biological assays.
ndophytes identiﬁcation
Strain BT04 was identiﬁed under responsibility of Dra. Lara D.
ette, microbiology specialist researcher in Centro Pluridisciplinar
e Pesquisas Químicas, Biológicas e Agrícolas (CPQBA), Universi-
ade de Campinas (Unicamp, Campinas, SP, Brazil). Genomic DNA
as extracted according to the procedure described in the literature
de Hoog et al., 2003). Using PCR, D1/D2 (DNAr 28S) and ITS1-5.8S-
TS2 regions were ampliﬁed using the respective primers: NL-1m
nd NL-4m; ITS-1 and ITS-4. The puriﬁed fragments sequencing
ere obtained in a MegaBACE 100 (GE Healthcare) automatic
equencer, using NL-1m, NL-2m, NL-3m and NI-4m for D1/D2
egion, and ITS-1 and ITS-4 for ITS region. Phylogenetic analysis
as carried out in a partial sequence comparing of D1/D2 and
TS regions and assembled in a contig (unique sequence combin-
ng different fragments), with the organisms sequences contained
n Genbank and CBS database. The sequences were aligned using
LUSTAL X program (Thompson et al., 1994) and phylogenetic
nalysis was conducted using Mega v3.0 program (Kumar et al.,armacognosia 25 (2015) 641–650 643
2004). The evolutionary distance matrix was calculated according
to Kimura (1980) model and the genetic tree was  proposed from
evolutionary distances made by Neighbor-Joining method (Saitou
and Nei, 1987), using bootstrap values calculated from 1000 resam-
pling, with the support of software included in MEGA 3.0 program.
Other nine strains (BT01–BT03; BT05–BT10) were identiﬁed
following the Sanger method (Sanger et al., 1977) by Genotyp-
ing Biotechnologia Ltd. (Botucatu, SP, Brazil). The microorganisms
were submitted to semi-solid growth in PDA, their DNA was
extracted and ampliﬁed by PCR for ITS region in Bio-Rad My
Cycler Thermal Cycler thermocycler. Sequentially, the reaction
was puriﬁed in agarose gel 1% and the sequencing was per-
formed using three different colonies and BigDye® Terminator v3.1
Cycle Sequencing kit. Capillary electrophoresis automatic sequenc-
ing was carried out using ABI 3730 Genetic Analyzer (Applied
Biosystems) and alignment of produced electropherograms against
respective sequencing (.ab1) of reference gene ITS deposit in Gen-
Bank.
Cytotoxicity activity (MTT assay)
The cytotoxicity activity was  evaluated against HL-60 (human
leukemia), HCT-8 (human colon carcinoma) and SF-295 (glioblas-
toma) cell lines acquired from National Cancer Institute, USA. Cells
were cultured in RPMI-1640 medium supplemented with 10% fetal
bovine serum, 2 mM glutamine, 100 g ml−1 streptomycin and
100 U ml−1 penicillin, and incubation at 37 ◦C with 5% CO2 atmo-
sphere. For experiments, the cells were added in 96-well plates
(1.0 × 105 cells/well for adherent cells or 0.5 × 105 cells/well for
suspended cells in 100 l of medium) and the samples (100 g ml−1
ﬁnal concentration) were added to each well (ﬁnal volume of
200 l) and incubated for 72 h. Control groups received the
same amount of sterile DMSO. Tumor cell growth was quan-
tiﬁed by the ability of living cells to reduce the yellow dye
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT)
to a purple formazan product. Sequentially, plates were centrifuged
and the medium was  replaced by 150 l of fresh medium contain-
ing 0.5 mg  ml−1 of MTT  and incubated for 3 h. The formazan salt
was dissolved in 150 l DMSO and the absorbance was  measured
using a multiplate reader (Multimode Detector DTX 880, Beckman
Coulter) (Berridge and Tan, 1993; Mosmann, 1983). Samples effect
was quantiﬁed as the percentage of control absorbance of reduced
dye at 595 nm.  Doxorubicin was  used as positive control.
Data for the MTT  were displayed as growth inhibition percent-
age in 100 g ml−1 ﬁnal concentration. For selected samples, it was
also measured the IC50 values and their respective conﬁdence inter-
vals were obtained by nonlinear regression using the GRAPHPAD
program v5.0 (Intuitive Software for Science, San Diego, USA).
Antifungal activity (bioautography assay)
The phytopathogenic microorganisms evaluated in the
antifungal assays C. sphaerospermum (Penzig) SPC 491 and
C. cladosporioides (Fresen) de Vries SPC 140 were cultured at the
Instituto de Botânica, São Paulo, SP, Brazil. Samples were dis-
solved in polarity-compatible solvents and applied to pre-coated
TLC plates. For each sample arrays (CE, HF, EF and MF), the TLC
plates were developed with organic solvent mixtures previously
established, as the mobile phase. After eluting, the plates were
dried for complete solvents removal. Chromatogram plates were
sprayed with a spore suspension of C. sphaerospermum or C.
cladosporioides in a glucose and salt solution and incubated for
72 h in a dark moistened chamber at 25 ◦C. A clear inhibition zone
appeared against a dark background, demonstrating favorable
sample activity. Nystatin was used as the positive control (Homans
and Fuchs, 1970).
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Fig. 1. Distribution of isolated strains from Bostrychia tenella according to superﬁcial
sterilization methods (black bar: PDA medium; gray bar: ADA medium).
Table 1
Identiﬁcation of endophytic strains associated to Bostrychia tenella specimens.
Strains code Identiﬁcation Similarity (%)
BT01 Trichoderma atroviride 99
BT02 Nigrospora oryzae 99
BT03 Phomopsis sp. 99
BT04 Penicillium decaturense 100
BT05 Xylaria sp. 99
BT06 Penicillium waksmanii 99
BT07 Xylariaceae sp. 99
BT08 Eurotium sp. 10044 R. de Felício et al. / Revista Brasileir
ntibacterial activity (minimum inhibitory concentration assay)
Minimum inhibitory concentration (MIC) values were deter-
ined by the microdilution broth method in 96-well microplates
National Committee for Clinical Laboratory Standards, NCCLS
2003)]. Standard strains from the American Type Culture
ollection of the following microorganisms were evaluated:
taphylococcus aureus Rosenbach 1884 (ATCC 6538) and Kleb-
iella pneumoniae (Schroeter 1886) Trevisan 1887 (ATCC 13883).
amples were dissolved in DMSO (1 mg  ml−1), followed by dilu-
ion in Mueller Hinton broth. Concentrations ranging from 400 to
5 g ml−1 were achieved. The ﬁnal DMSO content was 5% (v/v),
nd this solution was used as negative control. The inoculums
ere adjusted for each organism, to yield a cell concentration of
 × 105 colony forming units (CFU) ml−1, according to McFarland
cale (0.5). One inoculated well was included, to allow control of
he adequacy of the broth for organism growth. One non-inoculated
ell, free of antimicrobial agent, was also included, to ensure
edium sterility. Penicillin G and Streptomycin commercial stan-
ards were used as positive controls. The microplates (96-wells)
ere incubated at 37 ◦C for 24 h. Subsequently, resazurin (30 l) in
queous solution (0.02%) was added to the microplates, to indicate
icroorganism viability.
T05 strain (Xylaria sp.) fermentation and extraction
BT05 strain (identiﬁed as Xylaria sp.) was grown on PDA for
5–20 days at 30 ◦C. Ten plugs of mycelia agar were inoculated
nto 20 Erlenmeyer ﬂasks (500 ml)  containing autoclaved rice and
terilized seawater (90 g:90 ml)  for 28 days at room temperature
25 ± 2 ◦C). The mycelia mass was extracted with dichloromethane
nd methanol (2:1, 200 ml  each ﬂask, twice), overnight, ﬁltered
nder vacuum, and phases were separated. Organic phase (CH2Cl2)
as concentrated under reduced pressure, yielding 21 g of crude
xtract.
ytochalasin D puriﬁcation and characterization
For chromatography separation, 20 g of crude extract was  frac-
ionated by silica gel VLC using a stepwise gradient solvent system
f increasing polarity from 100% n-hexane to 100% MeOH, to
ield nine fractions (A–I). The fraction eluting with 100% EtOAc
fraction G) was puriﬁed using RP HPLC [Supelcosil TM LC-18,
50 mm × 10 mm,  5 m,  gradient elution: 5–80% MeCN/H2O (0.05%
ormic acid) in 40 min]. A major compound was  collected in
R = 24 min  (32 mg,  a 0.16% yield from crude extract).
Identiﬁcation of the cytochalasin D (1) was carried out using
pectroscopy techniques, including 1D and 2D nuclear magnetic
esonance (NMR) (1H, 13C, DEPT, COSY, HMQC and HMBC). NMR
pectra were obtained in Bruker spectrometer DRX-500 (Bruker
ptics, Billerica, MA,  USA) using CD3OD (Sigma–Aldrich) as a sol-
ent and the compound was identiﬁed by comparing their physical
roperties with the literature data (Xu et al., 2001). High-resolution
lectrospray ionization mass spectra (HRESIMS) were obtained on
n UltrO-TOF instrument (Bruker-Daltonics, Billerica, MA,  USA)
quipped with an ESI ion source. The sample was dissolved in
ethanol/water 4:1 (v/v) and infused into the ESI source at a ﬂow
ate of 5 l min−1, using a Harvard Apparatus model 1746 (Hollis-
on, MA,  USA) syringe pump.
esults
ndophytic microorganism isolation associated to Bostrychia
enella
Forty-ﬁve endophytic strains were isolated from B. tenella
hrough three SSM (SSM 1, 2 and 3) and by using two  semi-solidBT09 Acremonium sp. 99
BT10 Acremonium implicatum 99
medium PDA and ADA as carbon source for primary endophyte
development (Fig. 1). From SSM 1, 2 and 3 were obtained, respec-
tively, 11 (24%), 17 (38%) and 17 (38%) strains. From semi-solid
medium PDA and ADA were obtained, respectively, 26 (58%) and
19 (42%). Microbial growth was not observed on the control plates.
Endophytes identiﬁcation
Strains identiﬁcation is presented in Table 1.
Biological activities
CE, n-hexane, ethyl acetate and methanol-water fractions of ten
endophytic microorganisms, besides respective culture controls,
were submitted to three assays: cytotoxic activity using SF-295
(glioblastoma), HL-60 (leukemia) and HCT-8 (human colon carci-
noma) cell lines; antifungal activity against C. cladosporioides and C.
sphaerospermum phytopathogenic fungi; and antibacterial activity
against S. aureus and K. pneumoniae human pathogens. The culture
control (pure rice) samples were inactive in all biological evalua-
tions, indicating rice solid medium have not interfered in results.
The overall biological activities evaluations data are presented
in Table 2. Eight samples showed a cellular growth inhibition more
than 50% in at least one cancer cell line, in an assay that eval-
uated samples in a concentration of 100 g ml−1. Three samples
(HF06, EF04 and EF06) have exhibited efﬁcient cell growth inhibi-
tion (80–100%) in all the tumor cell lines. Considering this potential,
IC (sample concentration that promotes 50% of cell deaths) were50
obtained (Table 3). Fraction HF06 was  the most cytotoxic sample,
since its IC50 values obtained ranged in 0–1 g ml−1, comparable
to doxorubicin, especially for SF-295 tumor cell line.
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Table  2
Biological activities of extracts and organic fractions from endophytic fungi (associated to Bostrychia tenella).
Samples Cytotoxicity Antifungal Antibacterial
SF-295 HCT-8 HL-60 C. cladosporioides C. sphaerospermum S. aureus K. pneumoniae
R Rf P R Rf P R MIC  R MIC
CE01 3.74 ± 4.86 8.23 ± 6.02 11.20 ± 1.22 − b b − b b − >400 − >400
CE02  13.21± 7.70 12.91 ± 3.72 16.67 ± 0.27 − b b − b b − >400 − >400
CE03  18.36 ± 6.38 21.43 ± 1.19 19.37 ± 4.21 − b b − b b − >400 − >400
CE04  22.09 ± 8.46 20.69 ± 6.84 16.87 ± 0.82 + 0.87 2 + 0.84 2 − >400 − >400
CE05  32.10 ± 8.74 67.39 ± 46.11 22.83 ± 4.09 − b b − b b − >400 − >400
CE06  55.40 ± 11.03 92.32 ± 10.86 23.26 ± 20.32 + 0.86 1 + 0.83 1 − >400 − >400
CE07  23.04 ± 5.66 19.36 ± 4.80 24.06 ± 4.97 − b b − b b − >400 − >400
CE08  35.64 ± 2.60 44.10 ± 2.30 24.27 ± 2.12 − b b − b b − >400 − >400
CE09  16.88 ± 0.74 −13.43 ± 5.07 9.02 ± 1.00 − b b − b b − >400 − >400
CE10  22.19 ± 1.56 14.46 ± 1.54 6.16 ± 1.33 − b b − b b − >400 − >400
CECC  −2.69 ± 1.46 −1.13 ± 7.51 4.81 ± 0.61 − b b − b b − >400 − >400
HF01  1.53 ± 10.34 −2.02 ± 1.34 −13.02 ± 6.66 − b b + 0.32 1 − >400 − >400
HF02  5.46 ± 3.82 −13.80 ± 4.16 −12.49 ± 5.50 − b b − b b − >400 − >400
HF03  2.37 ± 8.46 39.00 ± 5.21 38.97 ± 4.49 − b b − b b + 400 − >400
HF04  1.78 ± 4.86 −8.02 ± 4.91 −31.86 ± 4.62 + 0.2 2 + 0.21 2 + 200 − >400
HF05  7.18 ± 1.80 −3.71 ± 1.49 −16.39 ± 16.31 − b b − b b − >400 − >400
HF06  93.05 ± 0.11 97.78 ± 0.00 92.23 ± 2.60 + Trail 3 + Trail 3 + ≤25 + 400
HF07  −9.65 ± 2.84 5.18 ± 7.81 −10.57 ± 0.75 − b b − b b − >400 − >400
HF08  −3.91 ± 0.14 −7.70 ± 2.83 −9.18 ± 1.09 − b b − b b − >400 − >400
HF09  14.44 ± 2.22 2.02 ± 4.83 2.84 ± 0.82 − b b − b b − >400 − >400
HF10  8.94 ± 0.28 −3.76 ± 0.22 −9.23 ± 0.88 − b b − b b + 100 − >400
HFCC  2.81 ± 7.01 8.76 ± 2.90 15.86 ± 11.62 − b b − b b − >400 − >400
EF01  7.18 ± 2.36 17.85 ± 0.15 82.17 ± 0.07 − b b − b b − >400 − >400
EF02  −6.32 ± 1.04 7.81 ± 3.35 4.76 ± 2.17 − b b − b b − >400 − >400
EF03  13.75 ± 4.30 28.32 ± 1.12 15.95 ± 4.42 − b b + 0.84/0.76 2/1 − >400 − >400
EF04  89.30 ± 6.38 87.90 ± 2.83 86.88 ± 1.97 + 0.83/0.21 2/3 + 0.89/0.22/0.12 3/1/1 + 400 − >400
EF05  58.74 ± 0.21 68.03 ± 1.49 29.17 ± 0.41 − b b − b b − >400 − >400
EF06  79.38 ± 1.06 88.46 ± 0.65 84.93 ± 1.86 + 0.85 1 − b b + 400 − >400
EF07  17.72 ± 0.49 19.43 ± 2.38 5.81 ± 1.22 − b b − b b − >400 − >400
EF08  50.84 ± 2.08 59.61 ± 0.00 30.37 ± 0.48 − b b − b b − >400 − >400
EF09  −4.31 ± 0.42 −18.43 ± 2.23 −2.74 ± 11.42 − b b − b b − >400 − >400
EF10  −14.07 ± 6.59 −6.39 ± 2.31 −5.57 ± 3.19 − b b − b b − >400 − >400
EFCC  6.14 ± 8.67 −1.50 ± 1.49 −2.21 ± 14.20 − b b − b b − >400 − >400
MF01  11.69 ± 0.69 4.55 ± 2.60 1.35 ± 2.79 − b b − b b − >400 − >400
MF02  11.30 ± 1.53 6.55 ± 2.75 1.35 ± 2.11 − b b − b b − >400 − >400
MF03  3.05 ± 1.53 −5.97 ± 9.15 8.89 ± 8.29 − b b − b b − >400 − >400
MF04  −14.17 ± 1.73 3.29 ± 5.88 7.88 ± 3.06 + 0.92 1 + 0.92 1 − >400 − >400
MF05  4.97 ± 0.76 5.29 ± 0.67 11.20 ± 1.36 − b b − b b − >400 − >400
MF06  11.89 ± 2.91 7.02 ± 0.30 6.73 ± 3.60 − b b − b b − >400 − >400
MF07  14.68 ± 0.76 12.38 ± 3.12 12.01 ± 1.02 − b b − b b − >400 − >400
MF08  12.42 ± 3.12 5.39 ± 0.97 3.41 ± 5.30 − b b − b b − >400 − >400
MF09  12.82 ± 2.29 4.71 ± 2.83 3.56 ± 3.74 − b b − b b − >400 − >400
MF10  10.71 ± 1.80 6.13 ± 0.37 3.99 ± 2.31 − b b − b b − >400 − >400
MFCC  8.11 ± 5.07 9.49 ± 3.05 0.14 ± 2.04 − b b − b b − >400 − >400
Doxorubicin 88.13 ± 1.74 93.09 ± 0.37 87.41 ± 0.31 a a a a a a a a a a
Nistatin a a a + 0 3 0 3 a a a a
DMSO 5% a a a a a a a a a − >400 − >400
Penicillin G a a a a a a a a a + 0.0028 a a
Streptomycin a a a a a a a a a a a + 0.7375
R, results; +, active; −, inactive; Rf , retention factor; P, potency; grade: 1 – weak, 2 – medium, 3 – strong.
C action
f
a
p
p
T
IE  means “crude extract”, HF means “n-hexane fraction”, EF means “ethyl-acetate fr
ront  of CE, HF, EF and MF means each strain (01–10).
a Not assayed.
b Not obtained.Nine evaluated samples displayed fungal growth inhibition in
t least one Cladosporium evaluated strain. HF06 and EF04 samples
rovided strong inhibition halos (3, in a scale from 0 to 3) in both
hytopathogenic fungi. HF01, EF03 and EF06 were active in only
able 3
C50 values for selected samples.
Samples Cytotoxicity
SF-295 HCT-8 HL-60
HF06 0.87 0.43 0.56
EF04  20.93 6.63 3.78
EF06 14.57 4.38 11.73
Doxorubicin 0.23 0.04 0.02”, MF  means “methanolic fraction”, CC means “control” (rice medium), numbers in
one fungi species, instigating the possibility of secondary metabo-
lites be acting selectively. Moreover, EF03 and EF04 presented more
than one inhibition spot, suggesting the presence of two  or more
active substances in each sample.
For antibacterial assay, ﬁve samples were active against
S. aureus,  highlighting HF06 sample for showing remarkable MIC
value against S. aureus (≤25 g ml−1) and for being active against
K. pneumoniae (400 g ml−1). Gram-positive and Gram-negative
bacteria feature antibiotic action mechanisms in distinguished
ways; therefore, HF06 should be supposedly composed by metabo-
lites comprising different antibiotic actions or even by a nonspeciﬁc
bacteria killer substance.
In addition, Figs. 2 and 3 were displayed to bring out other key
views about this biological screening. In Fig. 2, active samples were
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Fig. 2. Biological activities of Bostrychia tenella associated endophytes: distribution by evaluated assays.
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ssays).
lassiﬁed according biological assay – including count by cancer
ell line or fungi/bacteria strain evaluated. Concerning cytotoxicity,
Fs were the most active samples (11 of 18, or 61%), whereas HFs
5 of 7, or 71%) in antibacterial activity, and for antifungal, active
amples were balance arranged among crude and organic fractions.
n Fig. 3, comparative biological potential of individual endophytic
trains can be observed. Three strains (BT04, BT05 and BT06) have
xhibited impressive results, showing activity almost all assays;ndophytic strain (BT02, BT07 and BT09 have not showed any activity in evaluated
meanwhile other three strains (BT02, BT07, BT09) were not active
in none of them.
Cytochalasin D characterizationAccording to HRESIMS data (see in sequence), isolated pure crys-
tals corresponded to a compound formula C30H37NO6. Searching in
Dictionary of Natural Products (http://dnp.chemnetbase.com), and
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Table  4
Nuclear magnetic resonance of hydrogen-1 and carbon-13 for cytochalasin D (1) and comparison with literature data.
Structure position 13Ca 13Cb Structure position 1Ha 1Hb
1 173.64 176.77
3 53.53 55.06 3 a 3.22, m,  4.5, 4.0 1H 3.28, ddd, 8.2; 5.3; 2.6, 1H
4  46.96 47.93 4 2.84, m,  5.0, 2.0, 1H 2.88, m, 1H
5  49.96 49.77 5 b 2.14, t, 5.0, 1H 2.17, dd, 5.2; 2.6, 1H
6  147.46 151.04
7 69.80 72.47 7 a 3.80, d, 10.5, 1H 3.75, d, 10.1, 1H
8  32.63 33.56 8 b 2.83, m,  10.5, 5.0, 2.0, 1H 2.58–2.64, m,  1H
9  53.24 55.40
10 45.28 45.05 10 a 2.65, dd, 13.5, 9.5, 1H 2.70, dd, 13.2; 8.3, 1H
10  b 2.83, m,  13.5, 10.0, 2.5, 1H 2.89, m, 1H
11  13.63 13.63 11 0.95, d, 7.0, 3H 0.55, d, 6.7, 3H
12  114.50 113.63 12 5.09, s, 5.29, s 2H 4.97, s, 1H; 5.2, s, 1H
13  134.11 134.50 13 5.35, m,  15.5, 10.0, 5.0, 1H 5.26–5.31, m,  1H
14  130.59 129.02 14 5.65, dd, 15.5, 10.0, 1H 5.23–5.26, m,  1H
15  37.70 39.51 15 a 2.02, dd, 13.5, 5.0, 1H 1.99, dd, 12.8; 4.8, 1H
15  b 2.51, dd, 13.5, 11.0, 1H 2.32–2.42, m,  1H
16  42.29 43.54 16 b 2.73, m,  11.0, 4.5, 1H 2.85, m, 1H
17  210.23 211.83
18  77.66 79.46
19 127.08 131.94 19 5.15, dd, 16.0, 2.5, 1H 5.55, dd, 15.9; 9.7, 1H
20  132.26 133.57 20 6.11, dd, 16.0, 2.5, 1H 5.98, dd, 15.9; 2.5, 1H
21  77.26 78.35 21 a 5.63, t, 2.5, 1H 5.42, t, 2.3, 1H
22  19.39 19.87 22 1.20, d, 7.0, 3H 1.14, d, 7.0, 3H
23  24.16 24.75 23 1.51, s, 3H 1.48, s, 3H
1′ 137.21 138.52
2′ ,6′ 129.06 131.10
Ph-H 7.25, m,  15.0, 7.0, 1.5, 5H
7.28–7.32 (m,  2H)
3′ ,5′ 128.92 129.79
7.17–7.24 (m,  3H)
4′ 127.57 128.02
O(CO)CH3 169.69 171.92
OCO(CH3) 20.84 20.79
OAc 2.26, s, 3H 2.29, s, 3H
t
p
(
9
e
5
D
a
s
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t
s
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c
s
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p
cNH  
a NMR data obtained in our study (Bruker DRX 500 (11.7 T), sample in CD3OD.
b NMR  data from cytochalasin D (Xu et al., 2001).
hrough comparison of our NMR  data with previous reported, the
uriﬁed substance structure was established as cytochalasin D (1)
Table 4).
[M+H]+ m/z 508.2644 (calc. C30H38NO6+ 508.2694, error
.84 ppm), [M+Na]+ m/z 530.2470 (calc. C30H37NNaO6+ 530.2508,
rror 7.16 ppm), [M+K]+ m/z  546.2212 (calc. C30H37NKO6+
46.2247, error 6.4 ppm).
1
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iscussion
Brazil hosts huge biodiversity, distributed across several biomes
nd ecosystems, containing 10–20% of the world’s known living
pecies, many of which have not been described (Valli et al., 2012).
ur continental country is gifted by 8000 km of tropical and sub-
ropical marine coastline, bathed by Atlantic Ocean. Despite rising
cientiﬁc efforts, support of Brazilian researchers concerning inves-
igation of chemistry and biological properties of marine organisms
alls for a quantitative increasing (Blunt et al., 2014). Brazilian
eaweeds have unique characteristics that can be exploited to
reate the basis for new products and processes, such as novel
harmaceuticals (Pereira and Costa-Lotufo, 2012). However, asso-
iated microbiota remains poorly explored: from two  hundred5.53, brs, 1H –
eighty natural products isolated from Brazilian microorganisms
were reviewed and only 6% were sourced from marine macroalgae
endophytic fungi (Ioca et al., 2014). From our group contribution,
we reported antibacterial compounds from endophytic fungus Pho-
mopsis longicola isolated from the tropical red seaweed Bostrychia
radicans (Montagne) Montagne (Erbert et al., 2012). Herein, bio-
logical and chemistry data of endophytes from B. tenella species
has come to subsidize the development of marine natural products
research in Brazil.
Concerning the applied microbiological isolation, the milder
superﬁcial sterilization method (SSM 1) determined the lower
isolated strains number (11 or 24%), while the other two SSMs
(SSM 2 and 3) showed greater numbers of isolates (17 or 38%).
Regarding favorable semi-solid medium for development of endo-
phytic microorganisms from sterilized algae thalli, PDA medium
demonstrated to be more efﬁcient than ADA medium, since pro-
moted growth of 58% of isolates. Potato-dextrose culture media is
known by being nutritional rich, especially for comparing with an
adapted growth medium (ADA) – although marine red algae being
agar and sulfated polysaccharides producers (Kim et al., 2011). In
addition, non-growth in control plates conﬁrmed isolates as endo-
phytes, and validated superﬁcial sterilization methodology applied.
The literature is considerably poor in reports about microbial
isolation details from algae species, since the major reports do not
mention the sterilization time. The methodology proposed in this
work was adapted from (Proksch et al., 2010), where the authors
have described in details the fungi isolation from marine species.
However, they have not made any distinction regarding different
organic matrix, since they pointed out a sterilization method using
ethanol 70% in period of 60–120 s. As B. tenella has delicate thallus,
we decided to reduce the time to 15 s and also to use NaOCl as ster-
ilization agent. Schulz et al. (2008) used NaOCl 1–3% solutions with
success for sterilizing plant issues, after an optimization process.
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owever, they did not specify clearly the use of NaOCl in the algae
pecies.
B. tenella endophytes showed cytotoxic, antifungal and antibac-
erial activities in a range of intensity grades. Both Penicillium
ecaturense and P. waksmanii showed outstanding results in biolog-
cal screening, being active in almost all assays. We  can suggest the
roduction of different compounds with distinguished properties
r versatility, by acting in evaluated tests. Frequently, non-speciﬁc
echanism action is more related to toxicity to cell, even health
nes. Nevertheless, multipurpose metabolites are valuable to
nderstand target/metabolite interactions, and can be inspirational
or synthetic modiﬁcations aiming fewer adverse effects. On the
ther hand, ﬁve strains showed activity in 1–2 assays/targets, sug-
esting speciﬁc actions, adding promising value concerning further
ioguided studies.
The biological potential of marine algae endophytic microorgan-
sms has been reported along last years. Eighty unknown metabo-
ites from marine seaweed endophytic fungi were reviewed, some
f them described as cytotoxic, antifungal and antibacterial prop-
rties (Leandrini de Oliveira et al., 2012). Moreover, some reviews
ave listed ranges of endophytes metabolites with biological prop-
rties: 73 cytotoxic, 84 antifungal and 50 antibacterial compounds
 including human pathogenic microbial (Gunatilaka, 2006; Pupo
t al., 2009; Strobel et al., 2004; Tan and Zou, 2001).
From our ten selected strains, we obtained at least six gen-
ra. Penicillium,  Acremonium, Trichoderma, Phomopsis,  Eurotium and
ylaria have already been found from marine environment and/or
s endophytic fungi. However, some details about biodiversity,
cology, chemical and biological potential must be explored aiming
o understand the signiﬁcance of our results.
Most active strains were P. decaturense and P. waksmanii,  for dis-
laying positive results in all evaluated assays. Crude and all organic
ractions of both strains showed remarkably moderate/strong anti-
ungal properties. n-Hexane and ethyl acetate fractions of both
isplayed activity for S. aureus,  highlighting n-hexane fraction of
. waksmanii that was also active against Gram-negative K. pneu-
oniae. Crude, n-hexane and ethyl acetate fractions of P. waksmanii
nd ethyl acetate fraction of P. decaturense were cytotoxic to three
umor evaluated cell lines. For P. waksmanii n-hexane fraction, the
C50 value was ranged 0–1 g ml−1 for all three-tumor cell lines, an
mpressive result for non-puriﬁed sample.
Penicillium is a cosmopolitan genera and has been investigated
or many reasons, mainly because production of micotox-
ns, antibiotics, bioactive and pharmaceutical applied com-
ounds. Biosynthetic arsenal of Penicillium includes azaphilones,
ntriguing structural alkaloids, diketopiperazines, benzodiasepins,
uinolones, quinazolines, poliketides and cyclic peptides (Fineﬁeld
t al., 2012; Kozlovskii et al., 2013; Li, 2010; Schultze et al., 2010).
P. decaturense was ﬁrst reported as source of insecticide
lkaloids (Zhang et al., 2003). Recently, marine sponge derived
. decaturense was reported showing biotransformation and
iodegradation properties (Alvarenga et al., 2014; de Oliveira
t al., 2013). However, there is no report about P. decaturense
solation from marine algae, regarding either its biological prop-
rties or chemical proﬁle from ocean environment. In previous
hemical studies P. waksmanii was associated with some tryptofan-
ontaining alkaloids production (Kozlovskii et al., 1997). This
enicillin derivate species has already been isolated from brown
lgae Sargassum ringgoldianum Harvey, in which two  metabolites
howed signiﬁcant cytotoxicity in the P388 lymphocytic leukemia
ystem (Amagata et al., 1998). In addition, marine P. waksmanii was
esponsible by the production of antifungal compound griseofulvin,
etected by ESI-IT/MS (Petit et al., 2004). There are no data about
ntibacterial action of P. waksmanii.
The n-hexane fraction of Trichoderma atroviride exhibited weak
ntifungal activity against C. sphaerospermum and ethyl acetatearmacognosia 25 (2015) 641–650
fraction showed more than 80% inhibition growth of tumor cell HL-
60. Trichoderma species is known by producing several fungitoxic
cell-wall-degrading enzymes (and probably also peptaibol antibi-
otics – unusual linear polypeptides) and have also been adopted
as agents of biological control of plant pathogenic fungi (Daniel
and Filho, 2007). Peptaibols have also been showing cytotoxic
properties: atroviridins and derived compounds showed cytotox-
icity to human cancer cell lines in vitro and unprecedented 17-
and 19-residue peptaibiotics produced by marine-derived T. atro-
viride showed weak in vitro cytotoxity against KB cells (Carroux
et al., 2013). Trichoderma genera are already reported as a marine-
derived endophytic from sponges (El-Bondkly and El-Gendy, 2012),
however not as seaweed marine endophyte. Besides, neither T. atro-
viride was  mentioned in literature as marine endophytic fungi.
The n-hexane fraction of Phomopsis sp. showed a weak antibac-
terial potential against S. aureus (400 g ml−1) and showed
displayed moderate antifungal activity against C. sphaerosper-
mum. Dicerandrol C isolated from P. longicolla (endophyte from
marine red macroalgae B. radicans) displayed notable antibac-
terial/bacteriostatic effect against S. aureus and S. saprophyticus
(Erbert et al., 2012). Phomopsis endophytic strains are proliﬁc
producers of phomoxanthones, xanthone dimers derived from
secalonic acid, compounds remarkably antimicrobial, cytotoxic,
pro-apoptotic and immunostimulatory (Choi et al., 2013; Ding et al.,
2013; Ronsberg et al., 2013). Moreover, Phomopsis strains are very
versatile regarding biosynthesis of secondary metabolites, produc-
ing bioactive compounds from a variety of chemical structures
scaffold (Choi et al., 2013).
Eurotium sp. ethyl acetate fraction demonstrated moderate
tumor growth inhibition SF-295 and HCT-8. Eurotium cristatum,
endophyte from the marine alga Sargassum thunbergii (Mertens ex
Roth) Kuntze, provided isolation of anthraquinones derivatives and
antimicrobial indole alkaloids against Escherichia coli and Staphy-
lococcus aureus (Du et al., 2012, 2014). A marine algal associated
Eurotium herbariorum strain has produced a cytotoxic pyrrolidi-
noindoline diketopiperazine against K562 tumor cell line (Li et al.,
2013).
Acremonium implicatum n-hexane fraction showed antibacte-
rial properties against S. aureus (100 g ml−1). From literature,
A. chrysogenum is a producer of cephalosporin C, a pharmaceuti-
cal compound inhibitor of peptidoglycan biosynthesis in bacteria
(Martin et al., 2010). Although Acremonium sp. was isolated
from samples of marine macroalga Plocamium genus in Germany
(Pontius et al., 2008), A. implicatum has no report regarding occur-
rence as marine endophyte.
In our studies, Acremonium sp. extract and fractions were
inactive for evaluated assays, as well as Nigrospora oryzae and
Xylariaceae sp. strains. Nigrospora genera was reported as marine
endophyte from marine and mangrove plants providing a rich
chemistry and range bioactivity compounds (Chen et al., 2012;
Shang et al., 2012), but there is no register about being a marine
seaweed endophyte.
The Xylariaceae (Xylariales, Ascomycotina), a large family cov-
ering of around forty genera, has received notable attention over
the past decades regarding production of secondary metabolites
(Whalley and Edwards, 1995). For instance, the Xylariaceae fam-
ily is closely related to azaphilones, a fungi metabolite class, that
exhibits a wide range of interesting biological activities, such as
antimicrobial, antifungal, antiviral, antioxidant, cytotoxic, nemati-
cidal and anti-inﬂammatory activities (Schultze et al., 2010). In our
studies, despite Xylariaceae strain presented no positive results for
evaluated assays, Xylaria sp. crude extract and ethyl acetate frac-
tion showed moderate inhibition growth for tumor cell SF-295 and
HCT-8.
Xylaria is the largest genus of the family Xylariaceae (Xylariales,
Sordariomycetes) and presently includes 300 accepted species of
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tromatic pyrenomycetes. Xylaria species are widespread from the
emperate to the tropical zones in the terrestrial globe, and besides,
ungi of this genus have been shown to be potential sources of novel
econdary metabolites, and many of them possess biological activ-
ties relevant for drug discovery, including cytotoxic, antimalarial,
nd antimicrobial activities (Song et al., 2014). Despite widespread
ccurrence of Xylaria in marine environment, there are no reports
egarding being marine seaweed endophytic fungi.
Isolation of macrolide cytochalasin D (1) from Xylaria sp. has
videnced pharmaceutical potential of seaweed endophytic fungi.
ytochalasans comprise a diverse group of fungal polyketide-
mino acid hybrid metabolites with a wide range of distinctive
iological functions (Scherlach et al., 2010). Cytochalasin D was
rst described from Metarhizium anisopliae (Aldridge and Turner,
969), and despite being an isomeric metabolite of cytochalasin B
nd C, it had shown antibiotic and antitumor activity, by acting in
ctin polymerization (Scherlach et al., 2010). Cytochalasin D has
lready been reported as marine derived fungus, but literature has
ot data about this compound from marine seaweed endophytes.
We  can conclude that B. tenella presents a microbiological
otential and, not only this species but also Brazilian marine
acroalgae deserve more exploratory and deep investigations. Pro-
osed SSM were efﬁcient once promoted the achievement of 45
ndophytic strains. Cytotoxic, antifungal and antibacterial activi-
ies were revealed for CE and organic fractions, demonstrating the
mportance in developing a deep natural products investigation
iming to determine which substances are responsible by biologi-
al activities. Our work complains ﬁrst report of A. implicatum as
arine endophyte and Xylaria sp., T. atroviride and N. oryzae as
arine seaweed endophytes. In addition, we are reporting ﬁrst
ata about cytotoxic and antifungal properties of P. decaturense and
ntibacterial for both P. decaturense and P. waksmanii.  Cytochalasin
 isolation and characterization (ﬁrst time for this kind of organic
ource) came out in order to illustrate how chemically prospective
arine seaweed endophytic fungi can be. On this way, it is valu-
ble to mention that natural products chemistry approaches aiming
iscovery of bioactive metabolites have been applied using promis-
ng strains. In a short future, reports regarding chemical potential
f these endophytes will come to improve and enrich literature
ata concerning chemistry of marine fungi secondary metabolites.
urthermore, this study comes to encourage more microbiological
xploration in Brazilian marine coast, comprising a challenge for
urrent and next generation of researchers.
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